ALLURION TECHNOLOGIES(ALUR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALUR ALLURION TECHNOLOGIES

Not Yet Opened 12-18 16:00:00 EST

1.50

+0.00

0.00%

盘后1.47

-0.03-2.00%

19:36 EST

High1.53	Low1.31	Vol114.34K
Open1.52	D1 Closing1.50	Amplitude14.67%
Mkt Cap18.38M	Tradable Cap8.78M	Total Shares12.26M
T/O163.08K	T/O Rate1.95%	Tradable Shares5.86M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALUR","market":"US","secType":"STK","nameCN":"ALLURION TECHNOLOGIES","latestPrice":1.5,"timestamp":1766091600000,"preClose":1.5,"halted":0,"volume":114336,"hourTrading":{"tag":"盘后","latestPrice":1.47,"preClose":1.5,"latestTime":"19:36 EST","volume":1112,"amount":1529.8,"timestamp":1766104598575},"delay":0,"floatShares":5856000,"shares":12256600,"eps":-9.129916,"marketStatus":"Not Yet Opened","change":0,"latestTime":"12-18 16:00:00 EST","open":1.52,"high":1.53,"low":1.31,"amount":163075.48165439998,"amplitude":0.146667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.129916,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766134800000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":1.5,"preHourTrading":{"tag":"盘前","latestPrice":1.458,"preClose":1.5,"latestTime":"09:20 EST","volume":1399,"amount":2033.0500233999999,"timestamp":1766067649087},"postHourTrading":{"tag":"盘后","latestPrice":1.47,"preClose":1.5,"latestTime":"19:36 EST","volume":1112,"amount":1529.8,"timestamp":1766104598575},"volumeRatio":2.711633,"impliedVol":0.5858,"impliedVolPercentile":0.7},"requestUrl":"/m/hq/s/ALUR/tweets","defaultTab":"tweets","newsList":[{"id":"2586047709","title":"BRIEF-Allurion Reports 23% Weight Loss, 14% Lean Mass Gain On Combining Program With Tirzepatide","url":"https://stock-news.laohu8.com/highlight/detail?id=2586047709","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586047709?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:44","pubTimestamp":1764089080,"startTime":"0","endTime":"0","summary":"BRIEF-Allurion Reports 23% Weight Loss, 14% Lean Mass Gain On Combining Program With TirzepatideNov 25 (Reuters) - Allurion Technologies Inc ALUR.N:ALLURION ANNOUNCES INITIAL RESULTS ON COMBINING THE ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nTUABCDHPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561909.HKD","LU0238689110.USD","IE00B1BXHZ80.USD","IE00BKDWB100.SGD","IE00BJLML261.HKD","LU2236285917.USD","LU0198837287.USD","LU1267930730.SGD","LU0456855351.SGD","LU2602419157.SGD","LU0889565916.HKD","LU1064131342.USD","LU2357305700.SGD","LU0471298694.HKD","BK4192","LU2265009873.SGD","LU0640476718.USD","LU2491049909.HKD","LU0320765059.SGD","SGXZ81514606.USD","LU2237443978.SGD","LU2461242641.AUD","ALUR","LLY","LU2089984988.USD","LU2237438978.USD","LU1232071149.USD","LU0323591593.USD","LU0466842654.USD","LU2324357040.USD","LU0786609619.USD","LU0689472784.USD","LU0256863902.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","LU0109391861.USD","LU0385154629.USD","BK4588","LU2491050071.SGD","BK4585","IE00B4R5TH58.HKD","LU1988902786.USD","LU0097036916.USD","LU1280957306.USD","LU1366192091.USD","GB00BDT5M118.USD","LU2237443465.HKD","LU2491050154.USD","IE00B1XK9C88.USD","LU2360106947.USD"],"gpt_icon":1},{"id":"2586724874","title":"BUZZ-U.S. STOCKS ON THE MOVE-Applied Materials, CDW,  Kohl's","url":"https://stock-news.laohu8.com/highlight/detail?id=2586724874","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586724874?lang=en_us&edition=fundamental","pubTime":"2025-11-25 23:45","pubTimestamp":1764085504,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Applied Materials, CDW, Kohl'sEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL6N3X10WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1116320737.USD","CDE","LIXT","ZETA","FCX","ZM","LU2290526834.HKD","SG9999000418.SGD","CDW","SPOT","LU0323591593.USD","BBY","PTCT","ABCB","KSS","SCCO","AMAT","FIBK","DD","IRD","SYM","ATAT","FLY","HL","BK4541","SRPT","ALUR","UPWK","BK4548","LU1815336760.USD","VST","LU0784383803.USD","FLNC","ANF","KEYS","ADI","LU1066051498.USD","TITN","APD","IE00BN0W2T93.GBP","ESPR"],"gpt_icon":1},{"id":"2586713734","title":"Allurion reports initial results on Allurion Program, tirzepatide combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2586713734","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586713734?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:35","pubTimestamp":1764081318,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) announced initial results on the combination of the Allurion Program with low-dose tirzepatide therapy to optimize mus...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-reports-initial-results-on-allurion-program-tirzepatide-combination-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-reports-initial-results-on-allurion-program-tirzepatide-combination-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2586248479","title":"Allurion Reports 23% Weight Loss and Increased Lean Mass With Combined Balloon and Low-Dose Tirzepatide Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2586248479","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586248479?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:25","pubTimestamp":1764080711,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has announced initial results from a case series evaluating the combination of the Allurion Program with low-dose tirzepatide therapy. The study involved 76 patients who received the Allurion Smart Capsule followed by low-dose tirzepatide, with doses ranging from 2.5mg to a maximum of 5.0mg, which is lower than standard tirzepatide dosing. After 12 months, participants experienced an average total body weight loss of 23% and a 14% increase in lean body mass as a percentage of total body weight. All patients remained adherent to tirzepatide throughout the study period. Additional data from this combination approach is being collected and is expected to be presented at upcoming medical meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL9GBfDm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999006597.SGD","02018","BK1608","BK1607","BK1504","BK4192","ALUR","SG9999014674.SGD","BK1167","BK1500"],"gpt_icon":0},{"id":"2586947920","title":"Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and Glp-1 Adherence","url":"https://stock-news.laohu8.com/highlight/detail?id=2586947920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586947920?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:25","pubTimestamp":1764080701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nTUABCDHPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0198837287.USD","LU0466842654.USD","LU0672654240.SGD","LU0823434583.USD","SGXZ99366536.SGD","BK4192","LU0432979614.USD","ALUR","LU1548497426.USD","LU2265009873.SGD","LU0353189680.USD","IE00BJJMRZ35.SGD","IE0004445239.USD","LU0882574139.USD","LU1989771016.USD","LU1551013425.SGD","LU2087625088.SGD","LU0094547139.USD","LU2471134879.HKD","LU2471134796.USD","LLY","LU1814569148.SGD","LU2468319806.SGD","SG9999018865.SGD","LU0320765059.SGD","LU1023059063.AUD","LU0114720955.EUR","LU1057294990.SGD","SG9999015978.USD","LU0096364046.USD","IE00BKPKM429.USD","LU0109391861.USD","LU2237443465.HKD","LU2112291526.USD","LU0122379950.USD","LU2471134952.CNY","SG9999017495.SGD","LU0079474960.USD","LU2552382132.HKD","LU1720051108.HKD","LU2106854487.HKD","LU0354030438.USD","IE00BWXC8680.SGD","IE00BJLML261.HKD","LU2456880835.USD","LU0456855351.SGD","LU1232071149.USD","LU0256863811.USD","LU2471134523.USD","SG9999001176.USD"],"gpt_icon":0},{"id":"2586479204","title":"Allurion Technologies Inc - Average Weight Loss of 23% With 14% Increase in Lean Body Mass","url":"https://stock-news.laohu8.com/highlight/detail?id=2586479204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586479204?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:25","pubTimestamp":1764080701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nTUABCDHPQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGXZ51526630.SGD","IE0009355771.USD","LU2324357040.USD","ALUR","LU0889565916.HKD","SG9999017495.SGD","LU0353189763.USD","LU1291159041.SGD","BK4585","IE00BKPKM429.USD","LU2168564222.USD","GB00BDT5M118.USD","LU1974910355.USD","LU2265009873.SGD","LU0323591593.USD","LU0203201768.USD","LU0354030511.USD","LU1069344957.HKD","BK4588","IE00B2B36J28.USD","SG9999014906.USD","BK4516","LU1023059063.AUD","LU2112291526.USD","LLY","LU0354030438.USD","LU2357305700.SGD","LU0061475181.USD","IE00BJLML261.HKD","LU1712237335.SGD","LU2168564495.EUR","BK4534","LU2236285917.USD","LU0058720904.USD","LU2108987350.USD","LU0708995401.HKD","LU2237443978.SGD","LU1551013425.SGD","BK4533","IE00B4R5TH58.HKD","LU0094547139.USD","LU2237443549.SGD","LU1035775433.USD","LU2360106947.USD","LU2462157665.USD","LU1061106388.HKD","LU1989771016.USD","IE00B1BXHZ80.USD","LU0466842654.USD","LU1917777945.USD"],"gpt_icon":0},{"id":"2584375241","title":"Allurion Smart Capsule Delivers Superior Weight Loss and Body Composition in New Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2584375241","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584375241?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:01","pubTimestamp":1763647270,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has announced the publication of a new peer-reviewed, case-controlled study evaluating the Allurion Smart Capsule combined with lifestyle intervention compared to lifestyle intervention alone. The results, which have already been published, indicate that the combination of the Allurion Smart Capsule and individualized lifestyle intervention led to an average weight reduction of 20% and nearly twice as much fat reduction at 36 weeks, without adverse effects on muscle mass. The study, which included 1,143 patients with a BMI of 30 kg/m2 or higher, also reported that the safety profile of the Allurion Smart Capsule was better than bariatric surgery and GLP-1 therapy, with efficacy comparable to bariatric surgery and higher than high-dose GLP-1 therapy in real-world settings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL2L80GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1504","SG9999006597.SGD","BK1608","ALUR","BK1607","BK1500","SG9999014674.SGD","BK4192","BK1167","02018"],"gpt_icon":0},{"id":"2584013928","title":"Allurion Technologies Is Maintained at Neutral by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2584013928","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584013928?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:35","pubTimestamp":1763642100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALUR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 20, 2025 07:35 ET (12:35 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2584927223","title":"Allurion Announces Strategic Distribution Partnership With Prosurg Medical In Brazil To Pioneer New Approach Focused On Metabolically Healthy Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2584927223","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584927223?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:58","pubTimestamp":1763575094,"startTime":"0","endTime":"0","summary":"Allurion Technologies Inc ::*ALLURION ANNOUNCES STRATEGIC DISTRIBUTION PARTNERSHIP WITH PROSURG MEDICAL IN BRAZIL TO PIONEER NEW APPROACH FOCUSED ON METABOLICALLY HEALTHY WEIGHT LOSS*ALLURION TECHNOLO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD3QLWSx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2584953841","title":"Allurion Technologies Signs Distribution Partnership with ProSurg Medical in Brazil","url":"https://stock-news.laohu8.com/highlight/detail?id=2584953841","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584953841?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:00","pubTimestamp":1763474443,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. announced a strategic distribution partnership with ProSurg Medical, a Brazilian medical device company specializing in bariatric and obesity care. The collaboration aims to expand access to Allurion's metabolically healthy weight loss solutions in Brazil, leveraging ProSurg Medical's network of over 300 hospitals. The partnership is expected to increase access to providers offering the Allurion Program, including potential combinations with GLP-1 therapy, to enhance both short and long-term weight loss outcomes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via Business Wire  on November 18, 2025, an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL6xTPmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1608","ALUR","BK1607","BK1504","BK1167","SG9999014674.SGD","BK4192","02018","SG9999006597.SGD","BK1500"],"gpt_icon":0},{"id":"2584958043","title":"Allurion Technologies Inc - Partnership to Increase Access to Allurion Program With Glp-1 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2584958043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584958043?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:00","pubTimestamp":1763474403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUAQRGPN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2584771671","title":"Allurion Technologies Delays Quarterly Financial Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584771671","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584771671?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:08","pubTimestamp":1763413730,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has disclosed a delay in filing its Quarterly Report on Form 10-Q for the financial period ended September 30, 2025. The company cited the need for additional time to complete preparation and review of items occurring after the quarter end but expects to file the report within the allowed five-day extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL42HZLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02018","SG9999014674.SGD","SG9999006597.SGD","BK1504","BK1167","BK1608","BK4192","BK1607","ALUR","BK1500"],"gpt_icon":0},{"id":"2582805371","title":"Allurion Technologies Q3 revenue beats expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2582805371","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582805371?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:09","pubTimestamp":1762952966,"startTime":"0","endTime":"0","summary":"Allurion Technologies Q3 revenue beats expectationsOverviewAllurion Q3 revenue of $2.7 mln beats analyst expectations despite a year-over-year declineCompany reduced operating expenses by 29% and oper","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2582379731","title":"Allurion Technologies Q3 Adj. EPS $(1.18) Misses $(1.17) Estimate, Sales $2.658M Beat $2.350M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379731","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379731?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:03","pubTimestamp":1762952639,"startTime":"0","endTime":"0","summary":"Allurion Technologies (NYSE:ALUR) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(1.17) by 0.6 percent. This is a 66.29 percent increase over losses of $(3.50) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48800678/allurion-technologies-q3-adj-eps-1-18-misses-1-17-estimate-sales-2-658m-beat-2-350m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2582379401","title":"BRIEF-Allurion Technologies Q3 Revenue USD 2.658 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379401","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379401?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952447,"startTime":"0","endTime":"0","summary":"BRIEF-Allurion Technologies Q3 Revenue USD 2.658 Million\n\n\nNov 12 (Reuters) - Allurion Technologies Q3 income from operations USD -9.63 million.\n\nQ3 operating expenses USD 10.934 million\nQ3 gross profit USD 1.304 million\nQ3 pretax profit USD -11.875 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLXD7C81F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2582379971","title":"Allurion Technologies Q3 Operating Expenses USD 10.934 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379971?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLXD7C81F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2582327400","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2582327400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582327400?lang=en_us&edition=fundamental","pubTime":"2025-11-12 19:00","pubTimestamp":1762945200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·CI&T Inc. Class A                               3Q       .10        AMC. ·Digi Intl Inc.                                  4Q       .51    4:00 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURI","CRMT","ALUR","ACXP","GUTS","CREX","CRMD","RSKD","MGX","AFYA","CLBT","ASND","BEEM","ABOS","CELC","AIRG","ALH","ARDT","AEMD","ANNX","CCAP","AKRO","CABA","CSCO","ATXS","AFCG","AUTL","CAAP","CPRT","ALVO","ABSI","BLDP","ABEO","ALC","IBTA","PYPD","AEBI","ALMS","AMAT","ATAT","AVBP","TWFG","CINT","IMRX","AYTU","LUNG","BABA","ARCO","ARX"],"gpt_icon":1},{"id":"2582382362","title":"Allurion Technologies provides update on Smart Capsule approval process","url":"https://stock-news.laohu8.com/highlight/detail?id=2582382362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582382362?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:55","pubTimestamp":1762869318,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) announced it has passed critical milestones in the FDA pre-market approval process for the Allurion Smart Capsule. In ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-provides-update-on-smart-capsule-approval-process-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-provides-update-on-smart-capsule-approval-process-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2582223364","title":"Allurion Technologies Raises $5 Million in Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582223364","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582223364?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:53","pubTimestamp":1762869207,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has announced the completion of a $5 million private placement financing. The transaction included participation from both new and existing stockholders, as well as a strategic partner with expertise in obesity. This private placement significantly strengthens the company's financial position as it seeks FDA approval for its Allurion Smart Capsule.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief on November 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL6ZhBHx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999006597.SGD","SG9999014674.SGD","ALUR","BK1500","BK1607","02018","BK1608","BK4192","BK1504","BK1167"],"gpt_icon":0},{"id":"2582364465","title":"Allurion to Eliminate Debt Through Exchange for Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2582364465","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582364465?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:45","pubTimestamp":1762868730,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has announced a transaction to exchange all of its outstanding debt and obligations under its Revenue Interest Financing Agreements for shares of newly created Series B Convertible Preferred Stock. This exchange would result in the company being debt-free. The Series B Preferred Stock will be convertible into shares of common stock under certain circumstances. This move is part of Allurion's strategy to strengthen its financial position as it seeks FDA approval for its Allurion Smart Capsule.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via Business Wire  on November 11, 2025, and is solely responsib","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL3Qpp9v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","02018","SG9999006597.SGD","ALUR","SG9999014674.SGD","BK1167","BK1608","BK1607","BK1500","BK1504"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allurion.com","stockEarnings":[{"period":"1week","weight":-0.0964},{"period":"1month","weight":0.0563},{"period":"3month","weight":-0.3182},{"period":"6month","weight":-0.3534},{"period":"1year","weight":-0.8065},{"period":"ytd","weight":-0.8605}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.158705},{"month":2,"riseRate":0.5,"avgChangeRate":-0.096584},{"month":3,"riseRate":0.5,"avgChangeRate":-0.111067},{"month":4,"riseRate":0.8,"avgChangeRate":-0.016637},{"month":5,"riseRate":0.4,"avgChangeRate":-0.027612},{"month":6,"riseRate":0.6,"avgChangeRate":-0.080645},{"month":7,"riseRate":0.4,"avgChangeRate":-0.001912},{"month":8,"riseRate":0,"avgChangeRate":-0.216146},{"month":9,"riseRate":0.6,"avgChangeRate":-0.006532},{"month":10,"riseRate":0.6,"avgChangeRate":0.011644},{"month":11,"riseRate":0,"avgChangeRate":-0.149681},{"month":12,"riseRate":0.6,"avgChangeRate":0.022637}],"exchange":"NYSE","name":"ALLURION TECHNOLOGIES","nameEN":"ALLURION TECHNOLOGIES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALLURION TECHNOLOGIES(ALUR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ALLURION TECHNOLOGIES(ALUR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ALLURION TECHNOLOGIES,ALUR,ALLURION TECHNOLOGIES股票,ALLURION TECHNOLOGIES股票老虎,ALLURION TECHNOLOGIES股票老虎国际,ALLURION TECHNOLOGIES行情,ALLURION TECHNOLOGIES股票行情,ALLURION TECHNOLOGIES股价,ALLURION TECHNOLOGIES股市,ALLURION TECHNOLOGIES股票价格,ALLURION TECHNOLOGIES股票交易,ALLURION TECHNOLOGIES股票购买,ALLURION TECHNOLOGIES股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALLURION TECHNOLOGIES(ALUR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ALLURION TECHNOLOGIES(ALUR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction